Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.350
+0.190 (8.80%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Jyong Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 181 | - | - | - | - | - |
| Enterprise Value | 199 | - | - | - | - | - |
| Debt / Equity Ratio | -1.57 | -0.50 | -0.49 | -0.48 | -0.50 | -0.71 |
| Net Debt / Equity Ratio | -0.81 | -0.49 | -0.48 | -0.45 | -0.40 | -0.49 |
| Net Debt / EBITDA Ratio | -10.09 | -9.32 | -6.18 | -4.97 | -4.12 | -4.02 |
| Net Debt / FCF Ratio | - | -4.98 | -6.35 | -4.18 | -4.43 | -7.98 |
| Quick Ratio | 0.62 | 0.01 | 0.01 | 0.06 | 0.38 | 0.73 |
| Current Ratio | 0.62 | 0.02 | 0.13 | 0.19 | 0.42 | 1.08 |
| Return on Assets (ROA) | -5.44% | -17.59% | -20.57% | -19.45% | -13.49% | - |
| Return on Capital Employed (ROCE) | -19.00% | 35.70% | 46.50% | 68.00% | -76.60% | -34.60% |
Source: S&P Capital IQ. Standard template.
Financial Sources.